Suleyman Sahin

Basaksehir, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 75 publications

ASO Visual Abstract: Who is at Risk of Residual Tumor and Pathologic Upstaging at Second TURBT in Non-Muscle-Invasive Bladder Cancer?

ASO Visual Abstract: Who is at Risk of Residual Tumor and Pathologic Upstaging at Second TURBT in Non-Muscle-Invasive Bladder Cancer?

Journal: Annals of surgical oncology

Published: August 01, 2026

Who is at Risk of Residual Tumor and Pathologic Upstaging at a Second TURBT in Non-Muscle-Invasive Bladder Cancer?

Who is at Risk of Residual Tumor and Pathologic Upstaging at a Second TURBT in Non-Muscle-Invasive Bladder Cancer?

Journal: Annals of surgical oncology

Published: June 16, 2026

The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing.

The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing.

Journal: Journal of chemotherapy (Florence, Italy)

Published: January 24, 2024

Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study.

Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study.

Journal: Journal of cancer research and clinical oncology

Published: April 05, 2023

Factors affecting survival in operated gastric cancer.

Factors affecting survival in operated gastric cancer.

Journal: Surgical oncology

Published: September 20, 2022

The prognostic effect of pretreatment 18F-FDG PET/CT metabolic parameters in locally advanced Esophageal Squamous Cell Carcinoma treated with definitive chemoradiotherapy.

The prognostic effect of pretreatment 18F-FDG PET/CT metabolic parameters in locally advanced Esophageal Squamous Cell Carcinoma treated with definitive chemoradiotherapy.

Journal: Surgical oncology

Published: March 11, 2022

Chemoradiotherapy followed by surgery versus observation in esophageal squamous cell carcinoma.

Chemoradiotherapy followed by surgery versus observation in esophageal squamous cell carcinoma.

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Published: September 26, 2021

The Prognostic Value of Postoperative Lymph Node Ratio in Gastric Adenocarcinoma Patients Treated With Neoadjuvant Chemotherapy.

The Prognostic Value of Postoperative Lymph Node Ratio in Gastric Adenocarcinoma Patients Treated With Neoadjuvant Chemotherapy.

Journal: Cureus

Published: May 28, 2021

Factors Affecting Survival in Operated Esophageal Squamous Cell Carcinoma.

Factors Affecting Survival in Operated Esophageal Squamous Cell Carcinoma.

Journal: Journal of gastrointestinal cancer

Published: March 15, 2021

The Predictive Value of Baseline Volumetric PET/CT Parameters on Treatment Response and Prognosis in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.

The Predictive Value of Baseline Volumetric PET/CT Parameters on Treatment Response and Prognosis in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.

Journal: Journal of gastrointestinal cancer

Published: February 07, 2021

Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group.

Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group.

Journal: Journal of gastrointestinal cancer

Published: January 24, 2021

Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer.

Combination of trastuzumab and taxane-containing intensified chemotherapy in first-line treatment of HER2-positive advanced gastric cancer.

Journal: Tumori

Published: November 10, 2020

Showing 1-12 of 75

Last Updated: 09/26/2026